Concepedia

Author

David Goldstein

Prince of Wales HospitalORCID

Also Known As

Alison Biggs, Barbara B. Biesecker, D B Goldstein, D GOLDSTEIN, D Goldstein, D. Ferraro, D. Goldstein, D.B. Goldstein, DAVID GOLDSTEIN, Darlene R. Goldstein

683

Publications

31K

Citations

81

H-Index

308

Concepts

All Affiliations

Prince of Wales HospitalUNSW SydneyThe University of SydneyPeter MacCallum Cancer CentreMonash University
DG

About

David Goldstein is an author at Prince of Wales Hospital specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

15

24

1.1K

2

Education

11

11

533

3

Arts

6

6

252

4

Engineering

2

2

32

5

Business

1

1

285

David Goldstein

×

257

Publications

25.7K

Citations

73

H-Index

YearCitations

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm,

Journal of Clinical Oncology

2007

3.8K

Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection

John P. Neoptolemos, Deborah Stocken, Claudio Bassi,

JAMA

2010

1.4K

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang,

The Lancet

2018

1.3K

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Pascal Hammel, F. Huguet, Jean‐Luc Van Laethem,

JAMA

2016

1K

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

David Goldstein, Robert H. El-Maraghi, Pascal Hammel,

JNCI Journal of the National Cancer Institute

2015

656

Desmoplastic Reaction in Pancreatic Cancer

Minoti V. Apte, S. Park, Phoebe A. Phillips,

Pancreas

2004

583

Dating the Origin of the CCR5-Δ32 AIDS-Resistance Allele by the Coalescence of Haplotypes

J. Claiborne Stephens, David Reich, David Goldstein,

The American Journal of Human Genetics

1998

523

Cancer Patient Preferences for Communication of Prognosis in the Metastatic Setting

Rebecca Hagerty, Phyllis Butow, Peter Ellis,

Journal of Clinical Oncology

2004

492

Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells

Alain Vonlaufen, Swapna Joshi, Changfa Qu,

Cancer Research

2008

464

Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study

Juan W. Valle, Daniel H. Palmer, Richard Jackson,

Journal of Clinical Oncology

2014

445

Page 1